Prenatal Diagnosis and Fetal Therapy for 21-hydroxylase Deficiency ; A Case Discontinued Steroid Administration

Research output: Contribution to journalArticlepeer-review

Abstract

A woman who has a boy affected with 21-OH-D was given dexamethasone orally from 7 weeks of gestation (G7w). Genetic analyses revealed her fetus was unaffected and the steroid administration was discontinued at G14w. At G38w, the baby was born with normal female genitalia. Although prenatal treatment of 21-OH-D with dexamethasone has been utilized and has thought to be safe for both mother and fetus, some unfavorable effects might exist. For optimal prenatal diagnosis and treatment, an algorithm with case recording and follow-up system should be developed, in addition to the informed choice made by the parents at risk. Also, intimate communication among pediatricians, perinatologists, obstetricians, clinical geneticists and genetic laboratories is necessary.

Original languageEnglish
Pages (from-to)1225-1229
Number of pages5
JournalActa Obstetrica et Gynaecologica Japonica
Volume53
Issue number8
Publication statusPublished - 2001

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Prenatal Diagnosis and Fetal Therapy for 21-hydroxylase Deficiency ; A Case Discontinued Steroid Administration'. Together they form a unique fingerprint.

Cite this